Matches in Nanopublications for { ?s ?p "[C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance in patients with diabetes mellitus type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance in patients with diabetes mellitus type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP392934.RARQ6B-gSaNcRUFFxKveByvomQq5RYm-frSUNBVrsMW5Y130_assertion description "[C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance in patients with diabetes mellitus type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP392934.RARQ6B-gSaNcRUFFxKveByvomQq5RYm-frSUNBVrsMW5Y130_provenance.
- NP785541.RA5vowHi1jMJzAo44TPFdivrAHebwAxuY7Z_RgQt9Vn1M130_assertion description "[C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance in patients with diabetes mellitus type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785541.RA5vowHi1jMJzAo44TPFdivrAHebwAxuY7Z_RgQt9Vn1M130_provenance.